CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

YMCA of Southern Maine

The Y: Were for youth development, healthy living, and social responsibility

LifeGuard America

LifeGuard America is a Tulsa, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The CHC Alliance

The CHC Alliance is a company that specializes in FQHC Revenue Cycle Management and Billing & Credentialing. They help community health centers reach their maximum potential by providing expertise in the field and ensuring that FQHCs get paid every dol...

CanReg

CanReg, Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

A V Pulmonary Care

A V Pulmonary Care is a Lancaster, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.